Therapy of deep-seated fungal infections with 5-fluorocytosine.
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000867:Anterior Chamber; D001228:Aspergillosis / Q000188:drug therapy; D001232:Aspergillus fumigatus; D002176:Candida albicans; D002177:Candidiasis / Q000188:drug therapy; D003453:Cryptococcosis / Q000188:drug therapy; D003455:Cryptococcus neoformans; D003596:Cytosine / Q000031:analogs & derivatives*; D004352:Drug Resistance, Microbial; D005260:Female; D005437:Flucytosine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007634:Keratitis / Q000188:drug therapy; D007674:Kidney Diseases / Q000097:blood; D016030:Kidney Transplantation; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy*; D014184:Transplantation, Homologous
D000666:Amphotericin B; D003596:Cytosine; D005437:Flucytosine